1576 - 1600 of 6564 Results
Title
Year
-
OPENTitle: Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 38End Page: 42Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.017Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.01.017Citation Count: 32
-
OPENTitle: Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 47End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.017Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.02.017Citation Count: 8
-
OPENTitle: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 75End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013Best OA location URL: http://www.prd-journal.com/article/S1353802022002048/pdfCitation Count: 23
-
OPENTitle: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 43End Page: 48Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021Best OA location URL: http://www.prd-journal.com/article/S1353802022002176/pdfCitation Count: 11
-
OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 7
-
OPENTitle: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 79End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdfCitation Count: 84
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625Citation Count: 21
-
OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 11
-
OPENTitle: Analysis of voice as an assisting tool for detection of Parkinson's disease and its subsequent clinical interpretationJournal Name: Biomedical Signal Processing and ControlPublisher: Elsevier BVVol: 66Issue #:Start Page: 102415End Page: 102415Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.bspc.2021.102415Best OA location URL: https://doi.org/10.1016/j.bspc.2021.102415Citation Count: 65
-
OPENTitle: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s diseaseJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113908End Page: 113908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113908Citation Count: 7
- A conversation with Judith Campisi: Leader in the field of aging research2021OPENTitle: A conversation with Judith Campisi: Leader in the field of aging researchJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 69Issue #:Start Page: 101366End Page: 101366Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2021.101366Citation Count: 2
-
OPENTitle: Data imputation and compression for Parkinson's disease clinical questionnairesJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 114Issue #:Start Page: 102051End Page: 102051Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.artmed.2021.102051Best OA location URL: https://hal.science/hal-02570967/documentCitation Count: 30
-
OPENTitle: Subtle anomaly detection: Application to brain MRI analysis of de novo Parkinsonian patientsJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 125Issue #:Start Page: 102251End Page: 102251Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.artmed.2022.102251Best OA location URL: https://doi.org/10.1016/j.artmed.2022.102251Citation Count: 15
-
OPENTitle: Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognitionJournal Name: Brain, Behavior, and ImmunityPublisher: Elsevier BVVol: 101Issue #:Start Page: 182End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbi.2022.01.005Best OA location URL: https://doi.org/10.1016/j.bbi.2022.01.005Citation Count: 56
- Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease2022OPENTitle: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 24Start Page: 16801End Page: 16817Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605Citation Count: 24
- In-Home Falls Risk Assessment in Parkinson Disease: A Guide for Clinicians2021OPENTitle: In-Home Falls Risk Assessment in Parkinson Disease: A Guide for CliniciansJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol: 102Issue #: 10Start Page: 2051End Page: 2054Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.apmr.2021.04.001Citation Count: 3
-
OPENTitle: Deep Brain Stimulation for Parkinson’s Disease: Why Earlier Use Makes Shared Decision Making ImportantJournal Name: NeuroethicsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12152-022-09496-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12152-022-09496-w.pdfCitation Count: 4
-
OPENTitle: Dopamine denervation in the functional territories of the striatum: a new MR and atlas-based 123I-FP-CIT SPECT quantification methodJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 128Issue #: 12Start Page: 1841End Page: 1852Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-021-02434-9Best OA location URL: https://hal.sorbonne-universite.fr/hal-03668195Citation Count: 8
-
OPENTitle: Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 71Issue #:Start Page: 44End Page: 45Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.01.017Best OA location URL: http://www.prd-journal.com/article/S1353802020300237/pdfCitation Count: 8
-
OPENTitle: Motor Complications in Parkinson's Disease: 13‐Year Follow‐up of the CamPaIGN CohortJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 185End Page: 190Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.27882Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27882Citation Count: 90
-
OPENTitle: Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data SetsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 4Start Page: 464End Page: 464Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.5257Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2775977/jamaneurology_kia_2021_oi_200099_1617209045.71518.pdfCitation Count: 205
-
OPENTitle: Falls Risk in Relation to Activity Exposure in High-Risk Older AdultsJournal Name: The Journals of Gerontology: Series APublisher: Oxford University Press (OUP)Vol: 75Issue #: 6Start Page: 1198End Page: 1205Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/gerona/glaa007Best OA location URL: https://academic.oup.com/biomedgerontology/article-pdf/75/6/1198/33283332/glaa007.pdfCitation Count: 86
-
OPENTitle: Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanismsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 121Issue #: 6Start Page: 705End Page: 719Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s00401-011-0806-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-011-0806-2.pdfCitation Count: 65
-
OPENTitle: Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson DiseaseJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 66Issue #: 6Start Page: 554End Page: 561Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2009.04.005Best OA location URL: http://doi.org/10.1016/j.biopsych.2009.04.005Citation Count: 97
-
OPENTitle: Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long termJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 135Issue #: 1Start Page: 65End Page: 83Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-017-1792-9Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs00401-017-1792-9.pdfCitation Count: 226